Stay updated on Safety of Selonsertib, Firsocostat, & Cilofexor in NASH Clinical Trial
Sign up to get notified when there's something new on the Safety of Selonsertib, Firsocostat, & Cilofexor in NASH Clinical Trial page.

Latest updates to the Safety of Selonsertib, Firsocostat, & Cilofexor in NASH Clinical Trial page
- CheckyesterdayChange DetectedThe clinical trial record is now displayed, with details on the study design, eligibility criteria, treatment cohorts, outcomes, locations, and supporting documents.SummaryDifference88%

- Check7 days agoChange DetectedThe footer’s displayed site revision changed from v3.7.2 to v3.8.0, while the study page still shows a 403 Forbidden error.SummaryDifference0.2%

- Check15 days agoChange DetectedA site-wide banner announces an NIH terminology transition and links to updates and FAQs, stating that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference1%

- Check22 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check29 days agoChange DetectedThe footer revision number changes from v3.7.0 to v3.7.1 while the page continues to display a 403 error.SummaryDifference0.2%

- Check49 days agoChange DetectedA 403 Forbidden page replaces the study content for NCT02781584, preventing access to the study details on ClinicalTrials.gov. The change reflects an access restriction rather than a data update.SummaryDifference23%

Stay in the know with updates to Safety of Selonsertib, Firsocostat, & Cilofexor in NASH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Selonsertib, Firsocostat, & Cilofexor in NASH Clinical Trial page.